In the BPC-157 vs TB-500 comparison, BPC-157 is characterised as a local, angiogenesis-focused peptide most studied in tendon, ligament and gut tissue, while TB-500 is described as a systemic, cell-migration peptide studied across cardiac, neural and multi-tissue models
Many use this as a pre-workout or as a snack between meals to fight off hunger and/or to hit their protein macros
Increases platelet aggregation and clot risk
GLP-1 agonists should be initially prescribed at the lowest dose and slowly uptitrated to avoid gastrointestinal side effects
Research-chemical quality and identity Material sold as TB-500 may be the 7-mer fragment, the full-length protein, or a mixture, and purity/identity are not guaranteed in the research-chemical market
The side effects that occur, like reddening of the skin and urine and changes in heart rate and blood pressure are temporary and harmless